Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Articles published by PureTech Health plc

< Previous 1 2 3 4 5 Next >
PureTech Receives Orphan Drug Designation for Wholly Owned Candidate LYT-200 for the Treatment of Pancreatic Cancer
From PureTech Health plc
Via Business Wire
Tickers PRTC
PureTech Founded Entity Karuna Therapeutics and Zai Lab Announce Strategic Collaboration for Development, Manufacturing, and Commercialization of KarXT in Greater China
From PureTech Health plc
Via Business Wire
Tickers KRTX PRTC ZLAB
PureTech Announces Participation at the Jefferies London Healthcare Conference
From PureTech Health plc
Via Business Wire
Tickers PRTC
PureTech Is Pleased to Note Publication in Nature’s Scientific Reports Featuring the Gelesis Foundational Biomimetic Platform for Treating Obesity and Conditions Related to Diet-Induced Gut Damage
From PureTech Health plc
Via Business Wire
Tickers PRTC
PureTech Founded Entity Vedanta Biosciences Appoints Simona Levi as Chief Legal Officer and Corporate Secretary
From PureTech Health plc
Via Business Wire
Tickers PRTC
PureTech Founded Entity Vedanta Announces Positive Topline Phase 2 Data for VE303 in High-Risk C. difficile Infection and Exercise of $23.8 Million Option by BARDA
From PureTech Health plc
Via Business Wire
Tickers PRTC
PureTech Founded Entity Sonde Health Launches Vocal Biomarker Technology to Monitor Mental Health and Well-Being
From PureTech Health plc
Via Business Wire
Tickers PRTC
PureTech Founded Entity Akili Announces Topline Results from Shionogi Phase 2 Study in Japan
From PureTech Health plc
Via Business Wire
Tickers PRTC
PureTech Announces Publication of New Preclinical Research from Collaborators that Supports Mesenteric Lymphatic Dysfunction as a Potential Cause of and Therapeutic Target for Obesity and Insulin Resistance
From PureTech Health plc
Via Business Wire
Tickers PRTC
PureTech to Present at Oppenheimer Fall Healthcare Life Sciences and MedTech Summit
From PureTech Health plc
Via Business Wire
Tickers PRTC
PureTech Founded Entity Vor Biopharma Announces VOR33 Granted U.S. FDA Fast Track Designation for Acute Myeloid Leukemia
From PureTech Health plc
Via Business Wire
Tickers PRTC
PureTech Health plc – Half-Year Report
From PureTech Health plc
Via Business Wire
Tickers PRTC
PureTech Presents Phase 1 Data for LYT-100 at the European Respiratory Society International Congress 2021
From PureTech Health plc
Via Business Wire
Tickers PRTC
PureTech Founded Entity Akili Enters Strategic Licensing Agreement with TALi, Extending Akili Portfolio and Industry Leadership in Prescription Digital Therapeutics for Cognitive Impairments
From PureTech Health plc
Via Business Wire
Tickers PRTC
PureTech Announces the Appointment Julie Krop, M.D., as Chief Medical Officer
From PureTech Health plc
Via Business Wire
Tickers PRTC
PureTech Announces That Imbrium Therapeutics Has Exercised License Option to LYT-503/IMB-150 for Interstitial Cystitis/Bladder Pain Syndrome
From PureTech Health plc
Via Business Wire
Tickers PRTC
PureTech: Notice of Half-Yearly Results
From PureTech Health plc
Via Business Wire
Tickers PRTC
PureTech Founded Entity Akili Releases New Gameplay Features in the First and Only FDA-Cleared Video Game Treatment for Children With ADHD
From PureTech Health plc
Via Business Wire
Tickers PRTC
PureTech Founded Entity Vedanta Biosciences Completes $68 Million Series D Financing
From PureTech Health plc
Via Business Wire
Tickers PRTC
PureTech Founded Entity Gelesis, the Maker of Plenity®, to Become a Publicly Traded Company via Merger with Capstar Special Purpose Acquisition Corp.
From PureTech Health plc
Via Business Wire
Tickers PRTC
PureTech Founded Entity Vor Biopharma Announces Collaboration with Janssen to Develop Engineered Hematopoietic Stem Cell Transplants Combined with a Bi-Specific Antibody Therapy for Acute Myeloid Leukemia (AML)
From PureTech Health plc
Via Business Wire
Tickers PRTC
PureTech Founded Entity Sonde Health Announces Collaboration with Qualcomm Technologies for Use of Vocal Biomarker Technology on Qualcomm Snapdragon Mobile Platforms
From PureTech Health plc
Via Business Wire
Tickers PRTC
PureTech Announces Clinical Trial and Supply Agreement with BeiGene to Evaluate LYT-200 and Tislelizumab in Patients with Difficult-to-Treat Solid Tumors
From PureTech Health plc
Via Business Wire
Tickers PRTC
PureTech Founded Entity Vedanta Biosciences Announces New Data from Phase 1 Study of VE202 for the Treatment of Inflammatory Bowel Disease
From PureTech Health plc
Via Business Wire
Tickers PRTC
PureTech Founded Entity Karuna Therapeutics Announces Results from Phase 1b Trial Evaluating the Safety and Tolerability of KarXT in Healthy Elderly Volunteers
From PureTech Health plc
Via Business Wire
Tickers PRTC
PureTech Acquires Remaining Interest in Founded Entity Alivio Therapeutics
From PureTech Health plc
Via Business Wire
Tickers PRTC
Results of Annual General Meeting
From PureTech Health plc
Via Business Wire
Tickers PRTC
PureTech Founded Entity Gelesis Presents Findings on Plenity®-Induced Weight Loss at the American Association of Clinical Endocrinology (AACE) 2021 Annual Virtual Meeting
From PureTech Health plc
Via Business Wire
Tickers PRTC
PureTech Founded Entity Akili Secures $160 Million in Financing; Poised to Deliver on the Promise of Digital Therapeutics
From PureTech Health plc
Via Business Wire
Tickers PRTC
PureTech to Present at the Jefferies Virtual Healthcare Conference
From PureTech Health plc
Via Business Wire
Tickers PRTC
< Previous 1 2 3 4 5 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.